These results demonstrated that deactivation of HDAC5 and HDAC6 may mediate the anti‐hypertrophic effect of NaBu in Ang II‐induced cardiac hypertrophy, which is consistent with previous study showing that HDAC6 contributes to the pathology of cardiac hypertrophy.36 The gene discussed is HDAC5; the disease is cardiac hypertrophy.